Loading...

Alto Neuroscience, Inc.

ANRO•NYSE
Healthcare
Biotechnology
$25.47
$-0.35(-1.36%)
U.S. Market opens in 16h 41m

Alto Neuroscience, Inc. (ANRO) Stock Overview

Explore Alto Neuroscience, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap811.1M
P/E Ratio-13.14
EPS (TTM)$-2.19
ROE-0.48%
Fundamental Analysis

AI Price Forecasts

1 Month$18.79
3 Months$23.22
1 Year Target$9.84

ANRO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alto Neuroscience, Inc. (ANRO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 65.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $9.84.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -13.14 and a market capitalization of 811.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.67%
5-Day Change
12.69%
1-Month Change
14.06%
3-Month Change
49.18%
6-Month Change
315.55%
Year-to-Date (YTD) Change
42.64%
1-Year Change
975.85%
3-Year Change
22.66%
5-Year Change
22.66%
All-Time (Max) Change
22.66%

Contact Information

https://www.altoneuroscience.com
(650) 200-0412
369 South San Antonio Road, Mountain View, CA, 94022

Company Facts

76 Employees
IPO DateFeb 2, 2024
CountryUS
Actively Trading

Frequently Asked Questions